Global (United States, European Union and China) Influenza Vaccine Market Research Report 2019-2025

SKU ID :QYR-14390382 | Published Date: 29-Aug-2019 | No. of pages: 128
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Influenza Vaccine Market Size Growth Rate by Type (2019-2025) 1.3.2 Fluzone/Vaxigrip 1.3.3 FluMist 1.3.4 Fluarix and Flulaval 1.3.5 Anflu 1.3.6 Fluvax/Afluria 1.3.7 Flucelvax and Fluvirin 1.4 Market Segment by Application 1.4.1 Global Influenza Vaccine Market Share by Application (2019-2025) 1.4.2 Adults 1.4.3 Pediatrics 1.4.4 Senior Citizens 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Influenza Vaccine Market Size 2.1.1 Global Influenza Vaccine Revenue 2014-2025 2.1.2 Global Influenza Vaccine Sales 2014-2025 2.2 Influenza Vaccine Growth Rate by Regions 2.2.1 Global Influenza Vaccine Sales by Regions 2014-2019 2.2.2 Global Influenza Vaccine Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Influenza Vaccine Sales by Manufacturers 3.1.1 Influenza Vaccine Sales by Manufacturers 2014-2019 3.1.2 Influenza Vaccine Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Influenza Vaccine Revenue by Manufacturers (2014-2019) 3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) 3.3 Influenza Vaccine Price by Manufacturers 3.4 Key Manufacturers Influenza Vaccine Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Influenza Vaccine Market 3.6 Key Manufacturers Influenza Vaccine Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Fluzone/Vaxigrip Sales and Revenue (2014-2019) 4.1.2 FluMist Sales and Revenue (2014-2019) 4.1.3 Fluarix and Flulaval Sales and Revenue (2014-2019) 4.1.4 Anflu Sales and Revenue (2014-2019) 4.1.5 Fluvax/Afluria Sales and Revenue (2014-2019) 4.1.6 Flucelvax and Fluvirin Sales and Revenue (2014-2019) 4.2 Global Influenza Vaccine Sales Market Share by Type 4.3 Global Influenza Vaccine Revenue Market Share by Type 4.4 Influenza Vaccine Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Influenza Vaccine Sales by Application 6 United States 6.1 United States Influenza Vaccine Breakdown Data by Company 6.2 United States Influenza Vaccine Breakdown Data by Type 6.3 United States Influenza Vaccine Breakdown Data by Application 7 European Union 7.1 European Union Influenza Vaccine Breakdown Data by Company 7.2 European Union Influenza Vaccine Breakdown Data by Type 7.3 European Union Influenza Vaccine Breakdown Data by Application 8 China 8.1 China Influenza Vaccine Breakdown Data by Company 8.2 China Influenza Vaccine Breakdown Data by Type 8.3 China Influenza Vaccine Breakdown Data by Application 9 Rest of World 9.1 Rest of World Influenza Vaccine Breakdown Data by Company 9.2 Rest of World Influenza Vaccine Breakdown Data by Type 9.3 Rest of World Influenza Vaccine Breakdown Data by Application 9.4 Rest of World Influenza Vaccine Breakdown Data by Countries 9.4.1 Rest of World Influenza Vaccine Sales by Countries 9.4.2 Rest of World Influenza Vaccine Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 AstraZeneca 10.1.1 AstraZeneca Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Influenza Vaccine 10.1.4 Influenza Vaccine Product Introduction 10.1.5 AstraZeneca Recent Development 10.2 CSL 10.2.1 CSL Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Influenza Vaccine 10.2.4 Influenza Vaccine Product Introduction 10.2.5 CSL Recent Development 10.3 GlaxoSmithKline 10.3.1 GlaxoSmithKline Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Influenza Vaccine 10.3.4 Influenza Vaccine Product Introduction 10.3.5 GlaxoSmithKline Recent Development 10.4 Sanofi 10.4.1 Sanofi Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Influenza Vaccine 10.4.4 Influenza Vaccine Product Introduction 10.4.5 Sanofi Recent Development 10.5 Altimmune 10.5.1 Altimmune Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Influenza Vaccine 10.5.4 Influenza Vaccine Product Introduction 10.5.5 Altimmune Recent Development 10.6 BionVax 10.6.1 BionVax Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Influenza Vaccine 10.6.4 Influenza Vaccine Product Introduction 10.6.5 BionVax Recent Development 10.7 FluGen 10.7.1 FluGen Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Influenza Vaccine 10.7.4 Influenza Vaccine Product Introduction 10.7.5 FluGen Recent Development 10.8 Folia Biotech 10.8.1 Folia Biotech Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Influenza Vaccine 10.8.4 Influenza Vaccine Product Introduction 10.8.5 Folia Biotech Recent Development 10.9 Genentech 10.9.1 Genentech Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Influenza Vaccine 10.9.4 Influenza Vaccine Product Introduction 10.9.5 Genentech Recent Development 10.10 Green Cross 10.10.1 Green Cross Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Influenza Vaccine 10.10.4 Influenza Vaccine Product Introduction 10.10.5 Green Cross Recent Development 10.11 Medicago 10.12 Moderna Therapeutics 10.13 Novavax 10.14 Shijiazhuang Yiling Pharmaceutical 10.15 SK Chemicals 10.16 UNM Pharma 10.17 Vaccitec 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Influenza Vaccine Sales Channels 11.2.2 Influenza Vaccine Distributors 11.3 Influenza Vaccine Customers 12 Market Forecast 12.1 Global Influenza Vaccine Sales and Revenue Forecast 2019-2025 12.2 Global Influenza Vaccine Sales Forecast by Type 12.3 Global Influenza Vaccine Sales Forecast by Application 12.4 Influenza Vaccine Forecast by Regions 12.4.1 Global Influenza Vaccine Sales Forecast by Regions 2019-2025 12.4.2 Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
List of Tables and Figures Figure Influenza Vaccine Product Picture Table Influenza Vaccine Key Market Segments Table Major Manufacturers Influenza Vaccine Covered in This Report Table Global Influenza Vaccine Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Influenza Vaccine Sales Market Shar by Type 2014-2025 Figure Fluzone/Vaxigrip Figures Table Major Manufacturers of Fluzone/Vaxigrip Figure FluMist Figures Table Major Manufacturers of FluMist Figure Fluarix and Flulaval Figures Table Major Manufacturers of Fluarix and Flulaval Figure Anflu Figures Table Major Manufacturers of Anflu Figure Fluvax/Afluria Figures Table Major Manufacturers of Fluvax/Afluria Figure Flucelvax and Fluvirin Figures Table Major Manufacturers of Flucelvax and Fluvirin Table Global Influenza Vaccine Market Share by Application 2019-2025 (K Units) Figure Adults Use Case Figure Pediatrics Use Case Figure Senior Citizens Use Case Figure Influenza Vaccine Report Years Considered Figure Global Influenza Vaccine Market Size 2014-2025 (Million US$) Figure Global Influenza Vaccine Sales 2014-2019 (K Units) Table Global Influenza Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Influenza Vaccine Sales by Regions 2014-2019 (K Units) Table Global Influenza Vaccine Sales Market Share by Regions 2014-2019 Figure Global Influenza Vaccine Sales Market Share by Regions 2014-2019 Figure Global Influenza Vaccine Sales Market Share by Regions in 2019 Table Global Influenza Vaccine Revenue by Regions 2014-2019 (Million US$) Table Global Influenza Vaccine Revenue Market Share by Regions 2014-2019 Figure Global Influenza Vaccine Revenue Market Share by Regions 2014-2019 Figure Global Influenza Vaccine Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Influenza Vaccine Sales by Manufacturers (2014-2019) (K Units) Table Global Influenza Vaccine Sales Share by Manufacturers (2014-2019) Figure Global Influenza Vaccine Sales Share by Manufacturers in 2019 Table Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD) Table Influenza Vaccine Revenue Share by Manufacturers (2014-2019) Figure Influenza Vaccine Value Share by Manufacturers in 2019 Table Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Influenza Vaccine Price (2014-2019) (USD/Unit) Table Key Manufacturers Influenza Vaccine Plants/Factories Distribution Table Key Manufacturers Influenza Vaccine Area Served Table Date of Key Manufacturers Enter into Influenza Vaccine Market Table Key Manufacturers Influenza Vaccine Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Fluzone/Vaxigrip Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global FluMist Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Fluarix and Flulaval Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Anflu Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Fluvax/Afluria Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Flucelvax and Fluvirin Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Influenza Vaccine Sales by Type (2014-2019) (K Units) Table Global Influenza Vaccine Sales Share by Type (2014-2019) Figure Global Influenza Vaccine Sales Market Share by Type (2014-2019) Figure Global Influenza Vaccine Sales Market Share by Type in 2018 Table Global Influenza Vaccine Revenue by Type (2014-2019) (Million US$) Table Global Influenza Vaccine Revenue Share by Type (2014-2019) Figure Global Influenza Vaccine Revenue Market Share by Type (2014-2019) Figure Global Influenza Vaccine Revenue Market Share by Type in 2018 Table Influenza Vaccine Price by Type 2014-2019 (USD/Unit) Table Global Influenza Vaccine Sales by Application (2014-2019) (K Units) Table Global Influenza Vaccine Sales Share by Application (2014-2019) Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019) Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019) Figure United States Influenza Vaccine Sales Growth Rate 2014-2019 (K Units) Figure United States Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table United States Influenza Vaccine Sales by Company (2014-2019) (K Units) Table United States Influenza Vaccine Sales Market Share by Company (2014-2019) Figure United States Influenza Vaccine Sales Market Share by Company in 2019 Table United States Influenza Vaccine Sales by Type (2014-2019) (K Units) Table United States Influenza Vaccine Sales Market Share by Type (2014-2019) Figure United States Influenza Vaccine Market Share by Type in 2019 Table United States Influenza Vaccine Sales by Application (2014-2019) (K Units) Table United States Influenza Vaccine Sales Market Share by Application (2014-2019) Figure United States Influenza Vaccine Market Share by Application in 2019 Figure European Union Influenza Vaccine Sales Growth Rate 2014-2019 (K Units) Figure European Union Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table European Union Influenza Vaccine Sales by Company (2014-2019) (K Units) Table European Union Influenza Vaccine Sales Market Share by Company (2014-2019) Figure European Union Influenza Vaccine Sales Market Share by Company in 2019 Table European Union Influenza Vaccine Sales by Type (2014-2019) (K Units) Table European Union Influenza Vaccine Sales Market Share by Type (2014-2019) Figure 2018 European Union Influenza Vaccine Market Share by Type Table European Union Influenza Vaccine Sales by Application (2014-2019) (K Units) Table European Union Influenza Vaccine Sales Market Share by Application (2014-2019) Figure 2018 European Union Influenza Vaccine Market Share by Application Figure China Influenza Vaccine Sales Growth Rate 2014-2019 (K Units) Figure China Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table China Influenza Vaccine Sales by Company (2014-2019) (K Units) Table China Influenza Vaccine Sales Market Share by Company (2014-2019) Figure China Influenza Vaccine Sales Market Share by Company in 2019 Table China Influenza Vaccine Sales by Type (2014-2019) (K Units) Table China Influenza Vaccine Sales Market Share by Type (2014-2019) Figure China Influenza Vaccine Market Share by Type in 2019 Table China Influenza Vaccine Sales by Application (2014-2019) (K Units) Table China Influenza Vaccine Sales Market Share by Application (2014-2019) Figure China Influenza Vaccine Market Share by Application in 2019 Figure Rest of World Influenza Vaccine Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Influenza Vaccine Sales by Company (2014-2019) (K Units) Table Rest of World Influenza Vaccine Sales Market Share by Company (2014-2019) Figure Rest of World Influenza Vaccine Sales Market Share by Company in 2019 Table Rest of World Influenza Vaccine Sales by Type (2014-2019) (K Units) Table Rest of World Influenza Vaccine Sales Market Share by Type (2014-2019) Figure Rest of World Influenza Vaccine Market Share by Type in 2019 Table Rest of World Influenza Vaccine Sales by Application (2014-2019) (K Units) Table Rest of World Influenza Vaccine Sales Market Share by Application (2014-2019) Figure Rest of World Influenza Vaccine Market Share by Application in 2019 Table Rest of World Influenza Vaccine Sales by Countries (2014-2019) (K Units) Table Rest of World Influenza Vaccine Sales Market Share by Countries (2014-2019) Figure Rest of World Influenza Vaccine Sales Market Share by Countries in 2019 Table Rest of World Influenza Vaccine Revenue by Countries (2014-2019) (Million US$) Table Rest of World Influenza Vaccine Revenue Market Share by Countries (2014-2019) Figure Rest of World Influenza Vaccine Revenue Market Share by Countries in 2019 Figure Japan Influenza Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Japan Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units) Figure Korea Influenza Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Korea Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units) Figure India Influenza Vaccine Sales Growth Rate (2014-2019) (K Units) Figure India Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units) Table AstraZeneca Company Details Table AstraZeneca Description and Business Overview Table AstraZeneca Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Influenza Vaccine Sales Growth Rate (2014-2019) Table AstraZeneca Influenza Vaccine Sales Market Share in Global Market Table AstraZeneca Recent Development Table CSL Company Details Table CSL Description and Business Overview Table CSL Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table CSL Influenza Vaccine Sales Growth Rate (2014-2019) Table CSL Influenza Vaccine Sales Market Share in Global Market Table CSL Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Description and Business Overview Table GlaxoSmithKline Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Influenza Vaccine Sales Growth Rate (2014-2019) Table GlaxoSmithKline Influenza Vaccine Sales Market Share in Global Market Table GlaxoSmithKline Recent Development Table Sanofi Company Details Table Sanofi Description and Business Overview Table Sanofi Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Influenza Vaccine Sales Growth Rate (2014-2019) Table Sanofi Influenza Vaccine Sales Market Share in Global Market Table Sanofi Recent Development Table Altimmune Company Details Table Altimmune Description and Business Overview Table Altimmune Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Altimmune Influenza Vaccine Sales Growth Rate (2014-2019) Table Altimmune Influenza Vaccine Sales Market Share in Global Market Table Altimmune Recent Development Table BionVax Company Details Table BionVax Description and Business Overview Table BionVax Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table BionVax Influenza Vaccine Sales Growth Rate (2014-2019) Table BionVax Influenza Vaccine Sales Market Share in Global Market Table BionVax Recent Development Table FluGen Company Details Table FluGen Description and Business Overview Table FluGen Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table FluGen Influenza Vaccine Sales Growth Rate (2014-2019) Table FluGen Influenza Vaccine Sales Market Share in Global Market Table FluGen Recent Development Table Folia Biotech Company Details Table Folia Biotech Description and Business Overview Table Folia Biotech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Folia Biotech Influenza Vaccine Sales Growth Rate (2014-2019) Table Folia Biotech Influenza Vaccine Sales Market Share in Global Market Table Folia Biotech Recent Development Table Genentech Company Details Table Genentech Description and Business Overview Table Genentech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Genentech Influenza Vaccine Sales Growth Rate (2014-2019) Table Genentech Influenza Vaccine Sales Market Share in Global Market Table Genentech Recent Development Table Green Cross Company Details Table Green Cross Description and Business Overview Table Green Cross Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Green Cross Influenza Vaccine Sales Growth Rate (2014-2019) Table Green Cross Influenza Vaccine Sales Market Share in Global Market Table Green Cross Recent Development Table Medicago Company Details Table Moderna Therapeutics Company Details Table Novavax Company Details Table Shijiazhuang Yiling Pharmaceutical Company Details Table SK Chemicals Company Details Table UNM Pharma Company Details Table Vaccitec Company Details Figure Influenza Vaccine Value Chain Table Influenza Vaccine Distributors List Table Influenza Vaccine Customers List Table Global Influenza Vaccine Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure Global Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Table Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Market Share Forecast by Type 2019-2025 Table Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Market Share Forecast by Application 2019-2025 Table Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units) Figure Global Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025 Table Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025 Figure United States Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure United States Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure European Union Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure European Union Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure China Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure China Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure Japan Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure Japan Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure Korea Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure Korea Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure India Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure India Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Influenza Vaccine Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Influenza Vaccine Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
AstraZeneca CSL GlaxoSmithKline Sanofi Altimmune BionVax FluGen Folia Biotech Genentech Green Cross Medicago Moderna Therapeutics Novavax Shijiazhuang Yiling Pharmaceutical SK Chemicals UNM Pharma Vaccitec
  • PRICE
  • $3280
    $6560

Our Clients